Evidence map›Paper›PMID 40425479›Full record

ArticleAnnals of family medicine2025

Drug Toxicity and My Dad's Ethnicity.

Jaewon Yoon, David A Hirsh

Abstract readPersonal Narrative
In one paragraph

Article in Annals of family medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jaewon YoonHarvard Medical School, Boston, Massachusetts jaewon_yoon@hms.harvard.edu.
David A HirshHarvard Medical School, Boston, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

My Korean-American father experienced a severe drug eruption after receiving allopurinol for gout. Although commonly used as a first-line medication in the United States, in South Korea, allopurinol is only prescribed after human leukocyte antigen (HLA) testing due to the high frequency of an HLA allele associated with allopurinol-induced severe cutaneous adverse reactions. Given the complexity of the discourse around engaging race and ethnicity in medical practice, my father's experience led me to contemplate the current context of eliminating race from clinical decision making to address historical and ongoing injustices. Upon this reflection, I advocate for the separation of race and ethnicity to appropriately consider ethnicity when it may support quality and safety of care for all patients.

Indexed as

AllopurinolDrug EruptionsFathersGout SuppressantsAsianGoutHumansMaleUnited StatesAllopurinolGout Suppressantsethnicitymedical educationperspectiveracereflection

Identifiers

PMID40425479
PMCPMC12120155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.